Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

European Union approves new alternatives to animal testing of drugs and chemicals

23.03.2006
The Scientific Advisory Committee of the European Centre for the Validation of Alternative Methods (ECVAM) has approved six new alternative testing methods that will reduce the need for certain drugs and chemicals to be tested on animals.

The new tests use cell cultures rather than animals to establish the toxicity of cancer drugs and identify contaminated drugs. The tests approved today will not only reduce the number of animals needed for testing, but will also increase the accuracy of the tests, thereby making the products concerned safer. The role of ECVAM, which is based at the European Commission’s Joint Research Centre, is to replace, refine and reduce methods of animal testing for cosmetics, drugs and chemicals. Tests validated by ECVAM must be approved by its Scientific Advisory Committee, composed of representatives of the 25 member states, academia, industry and animal welfare organizations before they can be used in labs across Europe.

One of the tests is designed to assist the dosage of some highly toxic drugs used in chemotherapy for cancer, a disease which causes almost a million deaths in the EU every year. Using bone marrow culture from mice and cord blood cells from humans, a test has been developed that will decrease the risk of a lethal overdose in the first cohort of patients to which they are administered, a risk that cannot be identified during current preclinical testing strategies.

International studies have shown that this new test can provide more accurate predictions than testing on animals, so the new method will not only reduce the number of animals needed, but also increase the safety of patients.

Five of the new tests address the issue of bacteria. Our immune system is designed to guard us against bacteria. However it cannot distinguish between live and dead bacteria, and will react also against dead bacteria or part of them. A drug may be sterilised, but not necessarily free from all traces of bacteria and this can lead to side-effects such as fever, pain and shock. 200,000 rabbits are used every year to test the drugs before they are put on the market. The new method uses human immune cells grown in the laboratory, which can detect bacteria just as the human immune system does. This test will not only reduce the number of animals used in labs, but also the costs of testing. An added bonus is that these new tests are far more effective in finding contaminated drugs than the previous animal tests.

The work of ECVAM is funded from the EU’s Research Framework Programme, with support from Member States, industry and animal welfare organisations. By using advances in scientific knowledge, ECVAM will help to increase patient safety and animal welfare.

A conference in Brussels on 7 November 2005 entitled “Europe goes alternative” saw the adoption of a European Partnership with industry to promote alternative approaches to animal testing.

Berta Duane | alfa
Further information:
http://www.jrc.cec.eu.int

More articles from Life Sciences:

nachricht New photocatalyst speeds up the conversion of carbon dioxide into chemical resources
29.05.2017 | DGIST (Daegu Gyeongbuk Institute of Science and Technology)

nachricht Copper hydroxide nanoparticles provide protection against toxic oxygen radicals in cigarette smoke
29.05.2017 | Johannes Gutenberg-Universität Mainz

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>